Cargando…
SUN-465 Thyrotropin-Releasing Hormone-Degrading Ectoenzyme Controls Thyrotropin Secretion and Body Weight in Male Rodents
Thyrotropin-releasing hormone (TRH) is expressed in the brain, and a few peripheral tissues. Apart from controlling TSH secretion from the pituitary, it has an anorexic effect. TRH is a short-lived intercellular signaling molecule, hydrolyzed by the TRH-degrading ectoenzyme (TRH-DE), a narrow specif...
Autores principales: | Charli, Jean-Louis, Cote-Velez, Antonieta, Adair, Rodriguez-Rodriguez, Hernández-Ortega, Karina, Uribe, Rosa Maria, Anaya-Vergara, Mitzi, Pérez-Estrada, José, Matziari, Magdalini, Joseph-Bravo, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553202/ http://dx.doi.org/10.1210/js.2019-SUN-465 |
Ejemplares similares
-
The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?
por: Charli, Jean-Louis, et al.
Publicado: (2020) -
A Rare Case of Thyrotropin Secreting Pituitary Macroadenoma Primarily Treated With Somatostatin Analogue
por: Elsheikh, Arwa Mahmoud, et al.
Publicado: (2021) -
SAT-268 Thyrotropin Secreting Pituitary Adenoma Initially Misdiagnosed as Primary Hyperthyroidism in a Taiwanese Man
por: Lin, Yu-Yi, et al.
Publicado: (2020) -
MON-313 Thyrotropin-Secreting Pituitary Tumors: Clinical Features, Diagnostic Criteria and Treatment Outcomes in 28 Patients
por: Dimitrova, Diana A, et al.
Publicado: (2020) -
ODP359 Thyrotropin secreting pituitary microadenoma and lung adenocarcinoma treated with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) Erlotinib and Osimertinib: a case report
por: Di Ieva, Antonio, et al.
Publicado: (2022)